维普期刊资源整合服务平台（V6.5）

56篇 您的检索式：作者名="KRUITHOF E"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy显示文摘	De Rycke L Kruithof E Van Damme N	2003	Arthritis Rheum2003，48，4：	2
2	Effect of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study显示文摘	van den Bosch F Kruithof E Baeten D	2000	Annals of the Rheumatic Disease2000，，：	2
3	Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis 显示文摘	KRUITHOF E DERYCKE L VANDOOREN B	2006	Arthritis Rheum2006，54，6：	1
4	Synovial histopathology of psoriatic arthritis, both digo-and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis 显示文摘	Kruithof E Baeten D De Rycke L	2005	Arthritis Res Ther2005，7，3：	1
5	Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy显示文摘	De Rycke L Kruithof E Van Damme N	2003	Arthritis Rheum2003，48，4：	1
6	Distinct Synovial Immunopathologic Characteristics of Juvenile - Onset Spondylarthritis and Other Forms of Juvenile Idiopathic Arthritis显示文摘	KRUITHOF E VAN DEN BOSSCHE V DE RYCKE L	2006	ARTHRITIS & RHEUMATISM2006，54，8：	1
7	Plasminogen activation in human acute leukaemias显示文摘	SCHEMER A WOHLWEND A KRUITHOF E K	1999	Br J Haematol1999，105，4：	1
8	Rheumatoid factor,but not anti-cyclic citrullinated peptide antibodies,is modulated by infliximab treatment in rheumatoid arthritis 显示文摘	Recke L Verhelst X Kruithof E	2005	Ann Rheum Dis2005，64，：	1
9	Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study 显示文摘	VAN DEN BF KRUITHOF E BAETEN D	2000	Ann Rheum Dis2000，59，：	1
10	Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll- like receptor 4 in spondylarthropathy 显示文摘	De Rycke L Vandooren B Kruithof E	2005	Arthritis Rheum2005，52，7：	1
11	Impact of ozonation on disinfection and formation of biodegradable organic matter and bromate 显示文摘	Orlandini E Kruithof J C van der Hoek J P	1997	J Wat SRT - AQUA1997，46，1：	1
12	Tumor necrosis factor α Blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondytarthropathy显示文摘	De Ryche L Vandooren B Kruithof E	2005	Arthritis Rheum2005，52，7：	1
13	Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy显示文摘	Vandooren B Kruithof E Yu D T	2004	Arthritis Rheum2004，50，9：	1
14	Randomized double blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy 显示文摘	Van Den Bosch F Kruithof E Baeten D Herssens A de Keyser F Mielants H	2002	Arthritis Rheum2002，46，：	1
15	Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy显示文摘	VANDOOREN B KRUITHOF E YU D T	2004	Arthritis Rheum2004，50，9：	1
16	Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study 显示文摘	Van den Bosch F Kruithof E Baeten D	2000	Ann Rheum Dis2000，59，6：	1
17	Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondyloarthropathy显示文摘	VANDOOREN B KRUITHOF E YU D T	2004	Arthritis Rheum2004，50，：	1
18	Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy显示文摘	VAN DEN BOSCH F KRUITHOF E BAETEN D	2002	Arthritis Rheum2002，46，3：	1
19	Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis显示文摘	KRUITHOF E DE RYCKE L VANDOOREN B	2006	Arthritis Rheum2006，54，：	1
20	Randomized double-bllnd comparison of chimeric monoclonal antibody to tumor necrosis factor alpha(infliximab) versus placebo in active spondylarthropathy 显示文摘	VAN DEN BOSCH F KRUITHOF E BAETEN D	2002	Arthritis Rheum2002，46，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示